South America Tissue Engineering Market Forecast to 2028 – COVID

South America Tissue Engineering Market Forecast to 2028 – COVID-19 Impact and Regional Analysis – by Material Type (Synthetic Material, Biologically Derived Materials, and Others) and Application (Orthopedic, Musculoskeletal & Spine, Neurology, Cardiology & Vascular, Skin & Integumentary, Urology, GI & Gynecology, Cancer, and Others)

Report Code : BMIRE00025956 | Region : LAMEA | Industry : Biotechnology | Published Date : 16/Sep/2022

The tissue engineering market in South America is expected to grow from US$464.24 million in 2022 to US$913.73 million by 2028. It is estimated to grow at a CAGR of 10.2% from 2022 to 2028.

Tissue engineering and regenerative medicine (TERM) have been proposed and developed for more than 30 years. Although several successful attempts at tissue regeneration have been made, TERM is still in its infancy. There are many unanswered fundamental questions regarding the selection of cell sources, development of tissue-specific materials, specialized bioreactors, and the construction of complex organs. After all, most therapies or treatments aim to enhance tissue regeneration, and stem cell engineering has opened a new avenue in regenerative medicine. Tissue engineering can be applied to construct various tissues, including blood vessels, nerve tissues, skin, and bones. Several techniques involving new materials, new structures, and novel surface modifications of biomaterials are developed for stem cell engineering. Also, a deep understanding of the interactions between cells and biomaterials is needed. Advances in tissue engineering research and its methodology led to the formation of scaffolds for bioprinters and then to the decellularized organs. More research into processes is overcoming the shortcomings of previous methods. Improving knowledge in the biology of regeneration, development in microelectronics, and 3D printing technology helps overcome the hurdles. In additing, cell therapy is one of the fastest-growing segments of the regenerative medicine domain. Novartis’s Kymriah was the first cell therapy solution offered for the treatment of B-cell acute leukemia, which opened opportunities for the emerging treatment therapy. Moreover, RepliCel, a regenerative medicine provider, has a wide range of regenerative medicine products in pipeline, with three products—RCH-01, RCS-01, and RCT-01—in the development phase. Further, Sernova is engaged in the development of regenerative medicine technologies and has a huge pipeline of the products for various conditions, including diabetes, Hemophilia A, and hyperthyroidism. Therefore, rapid advancements in the development of regenerative medicines to provide effective solutions for chronic conditions are driving the growth of the market.

With new features and technologies, vendors can attract new customers and expand their footprints in emerging markets. This factor is likely to drive the South America tissue engineering market at a substantial CAGR during the forecast period.

South America Tissue Engineering Market Revenue and Forecast to 2028 (US$ Million)

South America Tissue Engineering Market Segmentation

The South America tissue engineering market is segmented on the basis of material type, application, and country. Based on material type, the market is segmented into biologically derived materials, synthetic materials, and others. In 2021, the biologically derived materials segment held the largest market share. However, the synthetic materials segment is expected to register the highest CAGR during the forecast period. Based on application, the market is segmented into orthopedic, musculoskeletal & spine, skin & integumentary, cardiology and vascular, neurology, cancer, gi & gynecology, urology, and others. In 2021, the orthopedic, musculoskeletal, & spine segment held the largest market share. However, the skin & integumentary segment is expected to register the highest CAGR in the market during the forecast period. Based on country, the South America tissue engineering market is segmented into Brazil, Argentina, and Rest of SAM. In 2021, Brazil held the largest market share; and it is also expected to grow at the fastest CAGR during the forecast period.

Zimmer Biomet; B. Braun Melsungen AG; Stryker Corporation; AbbVie, Inc.; Integra LifeSciences Holdings Corporation; Medtronic; Baxter International Inc.; Johnson and Johnson Services, Inc.; 3M; and Cook Biotech Inc. are among the leading companies in the South America tissue engineering market.

At 10.2% CAGR, the South America Tissue Engineering Market is speculated to be worth US$ 913.73 million by 2028, says The Insight Partners

According to The Insight Partners’ research, the South America tissue engineering market was valued at US$ 464.24 million in 2022 and is expected to reach US$ 913.73 million by 2028, registering an annual growth rate of 10.2% from 2022 to 2028. Fostering technological advancements in the field of 3d tissue engineering and widening advancements in regenerative medicine.

3D bioprinting has rapidly transformed the healthcare sector in the last few years. This technology has advanced the development of tissue with clinical potential, paving the way for high-throughput applications for drug discovery. 3D bioprinting tissue-engineering helps in the healing of injuries; new breakthroughs in the 3D printing technique are projected to offer a potential treatment option for organ failure in future. Many research organizations are working toward finding new therapies to treat organ failure and repair cells of damaged tissues. For instance, in 2017, researchers at Penn State University discovered a revolutionary way to print tissues and organs with the use of an “electrospinning printer” that spins fibers seeded with cells to create fiber layers. This technology is both cheaper and offers an opportunity to spin polymer fibers such as collagen layers with precision and in a more controlled manner. In addition to this, scientists at George R. Brown School of Engineering reported the construction of a 3D printed organ that mimics lungs. In April 2019, a researcher at Tel Aviv University printed the world’s first 3D engineered, vascularized heart using a patient’s own cells and biological materials. With advances in stem cell research, intelligent biomaterials, and three-dimensional biofabrication strategies, highly mimicked tissues or organs can be engineered. Future advances in bioprinting include the integration of different printing mechanisms to produce biphasic or triphasic tissues with optimized scaffolds and a further understanding of stem cell biology. More recently, 3D printing has promised tissue manufacturing with micro- to macro-scale structural control through a layer-by-layer approach. Through 3D reconstructions of scanned lesions, bioprinting can precisely deliver cells, growth factors, and biomaterial scaffolds to repair the lesion with different shapes and thicknesses. A promising direction is to combine the bioprinting approaches based on other mechanisms to meet the various challenges. Increasing government funding for research activities is expected to enhance the growth of the tissue engineering market.

On the contrary, high cost of treatment options involving tissue engineering.

Based on material type, the South America tissue engineering market is segment into biologically derived materials, synthetic materials, and others. The biologically derived materials segment held 52.6% market share in 2022, amassing US$ 244.05 million. It is projected to garner US$ 483.52 million by 2028 to expand at 10.3% CAGR during 2022–2028.

Based on application, the South America tissue engineering market is segmented into orthopedic, musculoskeletal, & spine, skin & integumentary, cardiology and vascular, neurology, cancer, gi, gynecology, urology, and others. The orthopedic, musculoskeletal, & spine segment held 34.3% market share in 2022, amassing US$ 159.30 million. It is projected to garner US$ 316.23 million by 2028 to expand at 10.3% CAGR during 2022–2028.

Based on country, the South America tissue engineering market has been segmented into the Brazil, Argentina, and Rest of SAM. Our regional analysis states that Brazil captured 44.2% market share in 2022. It was assessed at US$ 205.42 million in 2022 and is likely to hit US$ 415.17 million by 2028, exhibiting a CAGR of 10.6% during the forecast period.

Key players dominating the South America tissue engineering market are Zimmer Biomet; B. Braun Melsungen AG; Stryker Corporation; AbbVie, Inc.; Integra LifeSciences Holdings Corporation; Medtronic; Baxter International Inc.; Johnson and Johnson Services, Inc.; 3M; and Cook Biotech Inc. among others.

In Feb 2017 Allergan acquired LifeCell Corporation, a regenerative medicine company, to strengthen its medical aesthetic, breast implants and tissue expander product portfolio. In November 2021, Stryker announced that it had completed the previously announced acquisition of Wright Medical Group N.V., a global medical device company focused on extremities and biologics.

TABLE OF CONTENTS

1. Introduction

1.1 Scope of the Study

1.2 The Insight Partners Research Report Guidance

1.3 Market Segmentation

1.3.1 South & Central America Tissue Engineering Market – By Material Type

1.3.2 South & Central America Tissue Engineering Market – By Application

1.3.3 South & Central America Tissue Engineering Market – By Country

2. South & Central America Tissue Engineering Market Key Takeaways

3. Research Methodology

3.1 Coverage

3.2 Secondary Research

3.3 Primary Research

4. South & Central America Tissue Engineering – Market Landscape

4.1 Overview

4.2 PEST Analysis

4.3 Expert Opinion

5. South & Central Tissue Engineering Market – Industry Dynamics

5.1 Key Drivers

5.1.1 Burgeoning Number of Road Accidents and Trauma Injuries, and Elevating Incidence of Chronic Diseases

5.1.2 Fostering Technological Advancements in the Field of 3D Tissue Engineering

5.2 Key Market Restraints

5.2.1 High Cost of Treatment Options Involving Tissue Engineering

5.3 Key Market Opportunities

5.3.1 Advancements in the Healthcare Market Across the Region

5.4 Future Trends

5.4.1 Widening Advancements in Regenerative Medicine

5.5 Impact Analysis

6. South & Central America Tissue Engineering Market Analysis

6.1 South & Central America Tissue Engineering Market Revenue Forecast and Analysis

7. South & Central America Tissue Engineering Market Analysis – By Material Type

7.1 Overview

7.2 South & Central America Tissue Engineering Market Revenue Share, by Material Type (2022 and 2028)

7.3 Synthetic Material

7.3.1 Overview

7.3.2 Synthetic Material: Tissue Engineering Market – Revenue and Forecast to 2028 (US$ Million)

7.4 Biologically Derived Materials

7.4.1 Overview

7.4.2 Biologically Derived Materials: Tissue Engineering Market – Revenue and Forecast to 2028 (US$ Million)

7.5 Others

7.5.1 Overview

7.5.2 Others: Tissue Engineering Market – Revenue and Forecast to 2028 (US$ Million)

8. South & Central America Tissue Engineering Market By Application

8.1 Overview

8.2 South & Central America Tissue Engineering Market, by Application, 2022 and 2028 (%)

8.3 Orthopedic, Musculoskeletal & Spine

8.3.1 Overview

8.3.2 Orthopedic, Musculoskeletal & Spine: Tissue Engineering Market – Revenue and Forecast to 2028 (US$ Million)

8.4 Neurology

8.4.1 Overview

8.4.2 Neurology: Tissue Engineering Market – Revenue and Forecast to 2028 (US$ Million)

8.5 Cardiology & Vascular

8.5.1 Overview

8.5.2 Cardiology & Vascular: Tissue Engineering Market – Revenue and Forecast to 2028 (US$ Million)

8.6 Skin & Integumentary

8.6.1 Overview

8.6.2 Skin & Integumentary: Tissue Engineering Market – Revenue and Forecast to 2028 (US$ Million)

8.7 Cancer

8.7.1 Overview

8.7.2 Cancer: Tissue Engineering Market – Revenue and Forecast to 2028 (US$ Million)

8.8 GI & Gynaecology

8.8.1 Overview

8.8.2 GI & Gynaecology: Tissue Engineering Market – Revenue and Forecast to 2028 (US$ Million)

8.9 Urology

8.9.1 Overview

8.9.2 Urology: Tissue Engineering Market – Revenue and Forecast to 2028 (US$ Million)

8.10 Others

8.10.1 Overview

8.10.2 Others: Tissue Engineering Market – Revenue and Forecast to 2028 (US$ Million)

9. South & Central America Tissue Engineering Market Country Analysis

9.1 Overview

9.1.1 South & Central America: Tissue Engineering Market, by Country, 2022 & 2028 (%)

9.1.1.1 Brazil: – Revenue and Forecast to 2028 (US$ Million)

9.1.1.1.1 Brazil: Tissue Engineering Market – Revenue and Forecast to 2028 (US$ Million)

9.1.1.1.2 Brazil Tissue Engineering Market, by Material Type – Revenue and Forecast to 2028 (US$ Million)

9.1.1.1.3 Brazil Tissue Engineering Market, by Application – Revenue and Forecast to 2028 (US$ Million)

9.1.1.2 Argentina: Tissue Engineering Market – Revenue and Forecast to 2028 (US$ Million)

9.1.1.2.1 Argentina: Tissue Engineering Market – Revenue and Forecast to 2028 (US$ Million)

9.1.1.2.2 Argentina Tissue Engineering Market, by Material Type – Revenue and Forecast to 2028 (US$ Million)

9.1.1.2.3 Argentina Tissue Engineering Market, by Application – Revenue and Forecast to 2028 (US$ Million)

9.1.1.3 Rest of South & Central America: Tissue Engineering Market – Revenue and Forecast to 2028 (US$ Million)

9.1.1.3.1 Rest of South & Central America: Tissue Engineering Market – Revenue and Forecast to 2028 (US$ Million)

9.1.1.3.2 Rest of South & Central America Tissue Engineering Market, by Material Type – Revenue and Forecast to 2028 (US$ Million)

9.1.1.3.3 Rest of South & Central America Tissue Engineering Market, by Application – Revenue and Forecast to 2028 (US$ Million)

10. South & Central America Tissue Engineering Market Industry Landscape

10.1 Organic Developments

10.1.1 Overview

10.2 Inorganic Developments

10.2.1 Overview

11. Company Profiles

11.1 Zimmer Biomet

11.1.1 Key Facts

11.1.2 Business Description

11.1.3 Products and Services

11.1.4 Financial Overview

11.1.5 SWOT Analysis

11.1.6 Key Developments

11.2 B. Braun Melsungen AG

11.2.1 Key Facts

11.2.2 Business Description

11.2.3 Products and Services

11.2.4 Financial Overview

11.2.5 SWOT Analysis

11.2.6 Key Developments

11.3 Stryker Corporation

11.3.1 Key Facts

11.3.2 Business Description

11.3.3 Products and Services

11.3.4 Financial Overview

11.3.5 SWOT Analysis

11.3.6 Key Developments

11.4 AbbVie, Inc.

11.4.1 Key Facts

11.4.2 Business Description

11.4.3 Products and Services

11.4.4 Financial Overview

11.4.5 SWOT Analysis

11.4.6 Key Developments

11.5 Integra LifeSciences Holdings Corporation

11.5.1 Key Facts

11.5.2 Business Description

11.5.3 Products and Services

11.5.4 Financial Overview

11.5.5 SWOT Analysis

11.5.6 Key Developments

11.6 Medtronic

11.6.1 Key Facts

11.6.2 Business Description

11.6.3 Products and Services

11.6.4 Financial Overview

11.6.5 SWOT Analysis

11.6.6 Key Developments

11.7 Baxter International Inc.

11.7.1 Key Facts

11.7.2 Business Description

11.7.3 Products and Services

11.7.4 Financial Overview

11.7.5 SWOT Analysis

11.7.6 Key Developments

11.8 Johnson and Johnson Services, Inc.

11.8.1 Key Facts

11.8.2 Business Description

11.8.3 Products and Services

11.8.4 Financial Overview

11.8.5 SWOT Analysis

11.8.6 Key Developments

11.9 3M

11.9.1 Key Facts

11.9.2 Business Description

11.9.3 Products and Services

11.9.4 Financial Overview

11.9.5 SWOT Analysis

11.9.6 Key Developments

11.10 Cook Biotech Inc.

11.10.1 Key Facts

11.10.2 Business Description

11.10.3 Products and Services

11.10.4 Financial Overview

11.10.5 SWOT Analysis

11.10.6 Key Developments

12. Appendix

12.1 About The Insight Partners

12.2 Glossary of Terms

LIST OF TABLES.

Table 1.             Brazil Tissue Engineering Market, by Material Type – Revenue and Forecast to 2028 (US$ Million)

Table 2.             Brazil Tissue Engineering Market, by Application – Revenue and Forecast to 2028 (US$ Million)

Table 3.             Argentina Tissue Engineering Market, by Material Type – Revenue and Forecast to 2028 (US$ Million)

Table 4.             Rest of South & Central America Tissue Engineering Market, by Material Type – Revenue and Forecast to 2028 (US$ Million)

Table 5.             Organic Developments Done By Companies

Table 6.             Inorganic Developments Done By Companies

Table 7.             Glossary of Terms, South & Central America Tissue Engineering market

LIST OF FIGURES.

Figure 1.           South & Central America Tissue Engineering Market Segmentation

Figure 2.           South & Central America Tissue Engineering Segmentation - By Country

Figure 3.           South & Central America Tissue Engineering Market Overview

Figure 4.           The Biologically Derived Materials Segment Held Largest Share Of Material Type Segment In Tissue Engineering Market

Figure 5.           Brazil Is Expected to Show Remarkable Growth During the Forecast Period

Figure 6.           South & Central America Tissue Engineering Market, Industry Landscape

Figure 7.           South & Central America PEST Analysis

Figure 8.           South & Central America Tissue Engineering Market – Revenue Forecast and Analysis – 2020- 2028

Figure 9.           South & Central America Tissue Engineering Market Revenue Share, by Material Type (2022 and 2028)

Figure 10.        Synthetic Material: Tissue Engineering Market – Revenue and Forecast to 2028 (US$ Million)

Figure 11.        Biologically Derived Materials: Tissue Engineering Market – Revenue and Forecast to 2028 (US$ Million)

Figure 12.        Others: Tissue Engineering Market – Revenue and Forecast to 2028 (US$ Million)

Figure 13.        South & Central America Tissue Engineering Market, by Application, 2022 and 2028 (%)

Figure 14.        Orthopedic, Musculoskeletal & Spine: Tissue Engineering Market – Revenue and Forecast to 2028 (US$ Million)

Figure 15.        Neurology: Tissue Engineering Market – Revenue and Forecast to 2028 (US$ Million)

Figure 16.        Cardiology & Vascular: Tissue Engineering Market – Revenue and Forecast to 2028 (US$ Million)

Figure 17.        Skin & Integumentary: Tissue Engineering Market – Revenue and Forecast to 2028 (US$ Million)

Figure 18.        Cancer: Tissue Engineering Market – Revenue and Forecast to 2028 (US$ Million)

Figure 19.        GI & Gynecology: Tissue Engineering Market – Revenue and Forecast to 2028 (US$ Million)

Figure 20.        Urology: Tissue Engineering Market – Revenue and Forecast to 2028 (US$ Million)

Figure 21.        Others: Tissue Engineering Market – Revenue and Forecast to 2028 (US$ Million)

Figure 22.        South & Central America: Tissue Engineering Market, by Key Country – Revenue (2022) (US$ Million)

Figure 23.        South & Central America: Tissue Engineering Market, by Country, 2022 & 2028 (%)

Figure 24.        Brazil: Tissue Engineering Market – Revenue and Forecast to 2028 (US$ Million)

Figure 25.        Argentina: Tissue Engineering Market – Revenue and Forecast to 2028 (US$ Million)

Figure 26.          Rest of South & Central America: Tissue Engineering Market – Revenue and Forecast to 2028 (US$ Million)

The List of Companies - South America Tissue Engineering Market

● Zimmer Biomet

● B. Braun Melsungen AG

● Stryker Corporation

● AbbVie, Inc.

● Integra LifeSciences Holdings Corporation      

● Medtronic

● Baxter International Inc.

● Johnson and Johnson Services, Inc.

● 3M

● Cook Biotech Inc.

● Save and reduce time carrying out entry-level research by identifying the growth, size, leading players and segments in the South America tissue engineering market.

● Highlights key business priorities in order to assist companies to realign their business strategies

● The key findings and recommendations highlight crucial progressive industry trends in the South America tissue engineering market, thereby allowing players across the value chain to develop effective long-term strategies

● Develop/modify business expansion plans by using substantial growth offering developed and emerging markets

● Scrutinize in-depth South America market trends and outlook coupled with the factors driving the tissue engineering market, as well as those hindering it

● Enhance the decision-making process by understanding the strategies that underpin commercial interest with respect to client products, segmentation, pricing, and distribution

TOP